Longitudinal change in regional brain volumes in prodromal Huntington disease
暂无分享,去创建一个
Vincent A Magnotta | Jane S. Paulsen | Jane S Paulsen | Hans J Johnson | Christopher A Ross | Elizabeth H Aylward | P. Nopoulos | J. Mills | E. Aylward | C. Ross | V. Magnotta | D. Langbehn | H. Johnson | R. Pierson | A. Juhl | Douglas R Langbehn | James A Mills | Andrew R Juhl | Peggy C Nopoulos | Ronald K Pierson
[1] Nick C Fox,et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.
[2] S. Folstein,et al. Selective Loss of [3H]Kainic Acid and [3H]AMPA Binding in Layer VI of Frontal Cortex in Huntington's Disease , 1994, Experimental Neurology.
[3] H. Heinsen,et al. Cortical and striatal neurone number in Huntington's disease , 2004, Acta Neuropathologica.
[4] David S Tuch,et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.
[5] P. Goldman-Rakic,et al. Evidence for progression in frontal cortical pathology in late‐stage Huntington's disease , 2004, The Journal of comparative neurology.
[6] F Cendes,et al. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[7] J. Brandt,et al. The association of CAG repeat length with clinical progression in Huntington disease , 2006, Neurology.
[8] L. Wilkins. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease , 2011, Neurology.
[9] Nick C Fox,et al. Onset and Progression of Pathologic Atrophy in Huntington Disease: A Longitudinal MR Imaging Study , 2010, American Journal of Neuroradiology.
[10] Jane S. Paulsen,et al. Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[11] Kurt E. Weaver,et al. Longitudinal diffusion tensor imaging in Huntington's Disease , 2009, Experimental Neurology.
[12] N C Andreasen,et al. Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. , 1999, Journal of computer assisted tomography.
[13] Jane S. Paulsen,et al. Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study , 2009, Movement disorders : official journal of the Movement Disorder Society.
[14] Sarah A. J. Reading,et al. Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study , 2005, Psychiatry Research: Neuroimaging.
[15] Josephine Barnes,et al. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[16] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[17] G. Pearlson,et al. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. , 1996, Archives of neurology.
[18] Nick C Fox,et al. Whole‐brain atrophy as a measure of progression in premanifest and early Huntington's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[19] Elizabeth H. Aylward,et al. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease , 2007, Brain Research Bulletin.
[20] Greg Harris,et al. Structural MR image processing using the BRAINS2 toolbox. , 2002, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.
[21] Jane S. Paulsen,et al. CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[22] R. Roos,et al. Basal ganglia volume and clinical correlates in ‘preclinical’ Huntington’s disease , 2008, Journal of Neurology.
[23] Jane S. Paulsen,et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.
[24] C D Good,et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.
[25] Vincent A Magnotta,et al. Morphology of the cerebral cortex in preclinical Huntington's disease. , 2007, The American journal of psychiatry.
[26] J. Ashburner,et al. Progression of structural neuropathology in preclinical Huntington’s disease: a tensor based morphometry study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[27] J. Brandt,et al. Onset and rate of striatal atrophy in preclinical Huntington disease , 2004, Neurology.
[28] B Fischl,et al. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition , 2005, Neurology.
[29] Andrea Ciarmiello,et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] Stephanie Powell,et al. Registration and machine learning-based automated segmentation of subcortical and cerebellar brain structures , 2008, NeuroImage.